Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Daniel Berinstein (NPI 1366416406)

Field	Value
Entity Type	Individual
Organization	Daniel Berinstein
Address	5454 Wisconsin Ave
City	Chevy Chase
State	MD
ZIP	20815
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	February 15, 2006

Payer Source	Total Paid
Medicare	$4.3M
Medicaid	$0

Key Findings

This provider is operating as a procedure‑heavy retina practice: the dominant Medicare revenues are driven by intravitreal biologic injections and comprehensive ophthalmologic evaluation codes, led by J0178 ($2.1M, 48.4%), J2777 ($574.2K, 13.5%), and 92014 ($457.8K, 10.7%). The code mix — high-volume injectable biologics alongside high-volume comprehensive exams — is consistent with a retina specialist managing chronic retinal disease with in‑office injections and follow‑up visits.

Revenue is highly concentrated in a few services: the precomputed top 3 Medicare codes account for 72.6% of this provider’s total Medicare revenue, out of a total Medicare revenue of $4.3M. That concentration indicates the practice’s financial profile is heavily dependent on a small set of retina treatment and exam codes.

Payer mix is effectively single‑payer Medicare: lifetime Medicare revenue is $4.3M while Medicaid billing is listed as none on file. Analysts should treat this NPI as operating without a Medicaid footprint when modeling payer exposure or network participation.

The provider’s competitive standing on several retina and exam codes is notably strong nationally: J0178 ranks #187 of 3204 providers nationally (94th percentile; notably above typical national volume) and 92014 ranks #12 of 35415 providers nationally (100th percentile; extreme outlier), while retinal imaging 92134 ranks #95 of 26868 (100th percentile; extreme outlier) and extended ophthalmoscopy 92202 ranks #7 of 2327 (100th percentile; extreme outlier). Taken together, these ranks indicate a major national outlier in visit volume and retinal imaging and a significantly above‑typical presence in aflibercept injections.

Service‑line detail supports a high throughput injection and imaging workflow: procedural codes such as 67028 ($236.9K, 5.6%) and 92134 ($157.2K, 3.7%) appear with notable revenue and high national rank positions, suggesting routine performance of intravitreal injections and frequent retinal imaging/interpretation as core operational activities. This pattern aligns with a retina practice structured around repeated office‑based treatment cycles and diagnostic monitoring.

The provider’s mix includes both well‑established biologic codes and several unclassified/compounded drug codes that represent nontrivial Medicare spend: J3590 accounts for $392.1K (9.2%), J3490 for $61.6K (1.4%), and J7999 for $18.7K (0.4%). Payer analysts should note these categories when evaluating drug administration and coding practices for utilization review or formulary alignment, since unclassified/compounded lines can reflect variability in billed product mix.

Volume patterns show a combination of extreme outlier behavior on exam and imaging codes and otherwise typical volumes on many drug codes: examples of typical, unremarkable volume include J2777 (74th percentile) and J3590 (67th percentile), while extreme outlier labels appear on 92014, 92134, and 92202. This mixed profile suggests the provider is unusually high‑volume for encounters and diagnostics while maintaining a more typical national participation level for several drug administration codes.

The provider has long tenure in the Medicare system, with NPI enumeration dated 2006-02-15 (~20 years ago), indicating sustained participation and an established practice footprint. Longevity combined with concentrated Medicare revenue and extreme national volume on multiple exam and imaging codes supports classification as an experienced, high‑throughput retina specialist in the Medicare market.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,970	$690	$2.1M
J2777	Injection, faricimab‑svoa, 0.1 mg	19,800	$30	$574.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	4,320	$110	$457.8K
J3590	Unclassified biologics	170	$2,360	$392.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,120	$110	$236.9K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,370	$40	$157.2K
J2778	Injection, ranibizumab, 0.1 mg	590	$190	$111.5K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	310	$220	$65.6K
J3490	Unclassified drugs	30	$1,810	$61.6K
92202	The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece…	3,210	$10	$41.8K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Daniel Berinstein — 5 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	13	100	950	$690	$887.3K
J2777	19	70	8,520	$30	$487.3K
J2778	28	50	650	$180	$207.8K
J3590	1	20	50	$2,390	$128.9K
67028	20	120	700	$100	$101.5K
Q5128	8	20	200	$210	$78K
J3490	78	100	70	$450	$62.1K
92014	3	620	210	$90	$44K
67041	8	10	20	$1,060	$30.9K
92235	30	90	70	$110	$19.5K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Daniel Berinstein, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Alexander Melamud	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Jordana Fein	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Eric Weichel	MD	Ophthalmology Physician	$4.1M	$0
Gayatri Reilly	MD	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sundeep Kasi	VA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Daniel Berinstein, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Frederick Smith	MD	Medical Oncology Physician	$2.7M	$0
Richard Garfinkel	MD	Retina Specialist (Ophthalmology) Physician	$2.4M	$0
John Schreiber	MD	Diagnostic Radiology Physician	$2.3M	$0
Friendship Ambulatory Surgery Center, LLC	MD	Ambulatory Surgical Clinic/Center	$2.2M	$0
David Weng	MD	Medical Oncology Physician	$1.5M	$0
Hyland Cronin	MD	Dermatology Physician	$1.5M	$0
David Wolfe	MD	Rheumatology Physician	$1.4M	$0
Brian Do	MD	Retina Specialist (Ophthalmology) Physician	$1.2M	$0
Metropolitan Medical Partners LLC	MD	Ambulatory Surgical Clinic/Center	$1.2M	$0
Maral Skelsey	MD	Dermatology Physician	$1.1M	$0

Daniel Berinstein — Billing Profile & Reimbursement Data

Sign up for Daniel Berinstein — Billing Profile & Reimbursement Data policy alerts

Daniel Berinstein — Billing Profile & Reimbursement Data

Sign up for Daniel Berinstein — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References